$10,000 of AXON ENTERPRISE lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Support non-lethal legislation"
You can find more data on corporate lobbying on Quiver Quantitative.
AXON Congressional Stock Trading
Members of Congress have traded $AXON stock 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $AXON stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 01/13.
- SENATOR MARKWAYNE MULLIN has traded it 2 times. They made 0 purchases and 2 sales worth up to $100,000 on 12/18.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
AXON Insider Trading Activity
AXON insiders have traded $AXON stock on the open market 109 times in the past 6 months. Of those trades, 0 have been purchases and 109 have been sales.
Here’s a breakdown of recent trading of $AXON stock by insiders over the last 6 months:
- PATRICK W SMITH (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 12 sales selling 165,021 shares for an estimated $66,369,461.
- JEFFREY C KUNINS (CPO & CTO) has made 0 purchases and 35 sales selling 48,710 shares for an estimated $29,522,406.
- JOSHUA ISNER (PRESIDENT) has made 0 purchases and 31 sales selling 33,985 shares for an estimated $21,068,443.
- BRITTANY BAGLEY (COO & CFO) has made 0 purchases and 6 sales selling 9,825 shares for an estimated $6,027,070.
- MICHAEL GARNREITER has made 0 purchases and 14 sales selling 3,000 shares for an estimated $1,677,196.
- JULIE A CULLIVAN sold 1,261 shares for an estimated $860,077
- MATTHEW R MCBRADY has made 0 purchases and 8 sales selling 1,000 shares for an estimated $605,195.
- CAITLIN ELIZABETH KALINOWSKI sold 450 shares for an estimated $271,831
- JERI WILLIAMS sold 307 shares for an estimated $169,685
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
AXON Hedge Fund Activity
We have seen 509 institutional investors add shares of AXON stock to their portfolio, and 381 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL INTERNATIONAL INVESTORS removed 1,207,000 shares (-92.2%) from their portfolio in Q4 2024, for an estimated $717,344,240
- CAPITAL WORLD INVESTORS added 841,772 shares (+86.4%) to their portfolio in Q4 2024, for an estimated $500,281,935
- ALLIANCEBERNSTEIN L.P. added 812,337 shares (+273.8%) to their portfolio in Q4 2024, for an estimated $482,788,125
- GQG PARTNERS LLC added 804,867 shares (+inf%) to their portfolio in Q4 2024, for an estimated $478,348,555
- WELLINGTON MANAGEMENT GROUP LLP removed 694,808 shares (-63.6%) from their portfolio in Q4 2024, for an estimated $412,938,290
- BLACKROCK, INC. removed 521,707 shares (-6.6%) from their portfolio in Q4 2024, for an estimated $310,060,904
- CHAMPLAIN INVESTMENT PARTNERS, LLC removed 509,435 shares (-74.7%) from their portfolio in Q4 2024, for an estimated $302,767,409
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
AXON Analyst Ratings
Wall Street analysts have issued reports on $AXON in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JMP Securities issued a "Outperform" rating on 02/04/2025
- Needham issued a "Buy" rating on 10/22/2024
- Goldman Sachs issued a "Buy" rating on 10/22/2024
To track analyst ratings and price targets for AXON, check out Quiver Quantitative's $AXON forecast page.
AXON Price Targets
Multiple analysts have issued price targets for $AXON recently. We have seen 4 analysts offer price targets for $AXON in the last 6 months, with a median target of $612.5.
Here are some recent targets:
- An analyst from Barclays set a target price of $726.0 on 02/27/2025
- Meta Marshall from Morgan Stanley set a target price of $700.0 on 12/03/2024
- Joshua Reilly from Needham set a target price of $525.0 on 10/22/2024
- Michael Ng from Goldman Sachs set a target price of $441.0 on 10/22/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.